17 December 2024
17 December 2024
Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.
The two-day event included talks on subjects ranging from how to best utilise AI to how to build a stable CRO.
The FDA's decision was based on the Phase III clinical trial programme, ARCADIA.
WuXi AppTec and WuXi Biologics (Jiangsu, China) are looking to sell off sites in the US and Europe as the prospect of the Biosecure Act is deterring potential clients.
The EMA's decision is based on the early clinical outcomes from the ARTEMIS-001 study.
The partnership aims to facilitate the vaccine's supply for the Indian market.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
